{
"info": {
"nct_id": "NCT06799065",
"official_title": "A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer",
"inclusion_criteria": "* Patients with histologically confirmed solid tumors who have locally recurrent or metastatic disease, including HGSOC\n* Refractory to or relapsed after all standard therapies with proven clinical benefit, unless as deemed by the Investigator, the subject is not a candidate for standard treatment, there is no standard treatment, or the subject refuses standard treatment after expressing an understanding of all available therapies with proven clinical benefit\n* For the expansion cohorts, participants must have histological confirmation of HGSOC and be determined to be platinum-resistant, platinum-refractory, or platinum-intolerant\n* There is no limit to the number of prior treatment regimens\n* Have measurable or evaluable disease\n* Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Clinically unstable central nervous system (CNS) tumors or brain metastasis\n* Any other concurrent anti-cancer treatment, except for hormonal blockade\n* Has undergone a major surgery within 3 weeks of starting study treatment\n* Medical issue that limits oral ingestion or impairment of gastrointestinal function that is expected to significantly reduce the absorption of ATX-295, however participants with a functioning distal ileostomy or colostomy may be permitted on trial\n* Clinically significant (ie, active) or uncontrolled cardiovascular disease\n* Need to use proton pump inhibitors on study or H2-receptor antagonists for the dose escalation portion of the study.\n* Unable to transition off strong or moderate CYP3A4 inhibitors or strong inducers\n* Pregnancy or intent to breastfeed or conceive a child within the projected duration of treatment\n\nOther inclusion and exclusion criteria as defined in the study protocol",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Refractory to or relapsed after all standard therapies with proven clinical benefit, unless as deemed by the Investigator, the subject is not a candidate for standard treatment, there is no standard treatment, or the subject refuses standard treatment after expressing an understanding of all available therapies with proven clinical benefit",
"criterions": [
{
"exact_snippets": "Refractory to ... all standard therapies with proven clinical benefit",
"criterion": "refractory to standard therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "relapsed after all standard therapies with proven clinical benefit",
"criterion": "relapsed after standard therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "unless as deemed by the Investigator, the subject is not a candidate for standard treatment",
"criterion": "candidate for standard treatment",
"requirement": {
"requirement_type": "eligibility",
"expected_value": false
}
},
{
"exact_snippets": "there is no standard treatment",
"criterion": "availability of standard treatment",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "the subject refuses standard treatment after expressing an understanding of all available therapies with proven clinical benefit",
"criterion": "refusal of standard treatment",
"requirement": {
"requirement_type": "action",
"expected_value": "refusal"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Refractory to ... all standard therapies with proven clinical benefit",
"criterion": "refractory to standard therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "relapsed after all standard therapies with proven clinical benefit",
"criterion": "relapsed after standard therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "unless as deemed by the Investigator, the subject is not a candidate for standard treatment",
"criterion": "candidate for standard treatment",
"requirement": {
"requirement_type": "eligibility",
"expected_value": false
}
},
{
"exact_snippets": "there is no standard treatment",
"criterion": "availability of standard treatment",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "the subject refuses standard treatment after expressing an understanding of all available therapies with proven clinical benefit",
"criterion": "refusal of standard treatment",
"requirement": {
"requirement_type": "action",
"expected_value": "refusal"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* For the expansion cohorts, participants must have histological confirmation of HGSOC and be determined to be platinum-resistant, platinum-refractory, or platinum-intolerant",
"criterions": [
{
"exact_snippets": "histological confirmation of HGSOC",
"criterion": "HGSOC",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "platinum-resistant, platinum-refractory, or platinum-intolerant",
"criterion": "platinum status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"platinum-resistant",
"platinum-refractory",
"platinum-intolerant"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "histological confirmation of HGSOC",
"criterion": "HGSOC",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "platinum-resistant, platinum-refractory, or platinum-intolerant",
"criterion": "platinum status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"platinum-resistant",
"platinum-refractory",
"platinum-intolerant"
]
}
}
]
}
},
{
"identified_line": {
"line": "* There is no limit to the number of prior treatment regimens",
"criterions": [
{
"exact_snippets": "no limit to the number of prior treatment regimens",
"criterion": "prior treatment regimens",
"requirement": {
"requirement_type": "quantity",
"expected_value": "no limit"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "no limit to the number of prior treatment regimens",
"criterion": "prior treatment regimens",
"requirement": {
"requirement_type": "quantity",
"expected_value": "no limit"
}
}
]
}
},
{
"identified_line": {
"line": "* Have measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "measurable",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
},
{
"exact_snippets": "evaluable",
"criterion": "disease",
"requirement": {
"requirement_type": "evaluability",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "measurable",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
},
{
"exact_snippets": "evaluable",
"criterion": "disease",
"requirement": {
"requirement_type": "evaluability",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "Key",
"criterions": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Key",
"criterion": "key",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Clinically unstable central nervous system (CNS) tumors or brain metastasis",
"criterions": [
{
"exact_snippets": "Clinically unstable central nervous system (CNS) tumors",
"criterion": "central nervous system (CNS) tumors",
"requirement": {
"requirement_type": "stability",
"expected_value": "clinically unstable"
}
},
{
"exact_snippets": "Clinically unstable ... brain metastasis",
"criterion": "brain metastasis",
"requirement": {
"requirement_type": "stability",
"expected_value": "clinically unstable"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Clinically unstable central nervous system (CNS) tumors",
"criterion": "central nervous system (CNS) tumors",
"requirement": {
"requirement_type": "stability",
"expected_value": "clinically unstable"
}
},
{
"exact_snippets": "Clinically unstable ... brain metastasis",
"criterion": "brain metastasis",
"requirement": {
"requirement_type": "stability",
"expected_value": "clinically unstable"
}
}
]
}
},
{
"identified_line": {
"line": "* Has undergone a major surgery within 3 weeks of starting study treatment",
"criterions": [
{
"exact_snippets": "Has undergone a major surgery within 3 weeks",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Has undergone a major surgery within 3 weeks",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "weeks"
}
}
}
}
},
{
"identified_line": {
"line": "* Medical issue that limits oral ingestion or impairment of gastrointestinal function that is expected to significantly reduce the absorption of ATX-295, however participants with a functioning distal ileostomy or colostomy may be permitted on trial",
"criterions": [
{
"exact_snippets": "Medical issue that limits oral ingestion",
"criterion": "oral ingestion",
"requirement": {
"requirement_type": "limitation",
"expected_value": true
}
},
{
"exact_snippets": "impairment of gastrointestinal function that is expected to significantly reduce the absorption of ATX-295",
"criterion": "gastrointestinal function",
"requirement": {
"requirement_type": "impairment",
"expected_value": true
}
},
{
"exact_snippets": "participants with a functioning distal ileostomy or colostomy may be permitted",
"criterion": "distal ileostomy or colostomy",
"requirement": {
"requirement_type": "functioning",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Medical issue that limits oral ingestion",
"criterion": "oral ingestion",
"requirement": {
"requirement_type": "limitation",
"expected_value": true
}
},
{
"exact_snippets": "impairment of gastrointestinal function that is expected to significantly reduce the absorption of ATX-295",
"criterion": "gastrointestinal function",
"requirement": {
"requirement_type": "impairment",
"expected_value": true
}
}
]
}
]
},
"then_criteria": {
"not_criteria": {
"exact_snippets": "participants with a functioning distal ileostomy or colostomy may be permitted",
"criterion": "distal ileostomy or colostomy",
"requirement": {
"requirement_type": "functioning",
"expected_value": true
}
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Need to use proton pump inhibitors on study or H2-receptor antagonists for the dose escalation portion of the study.",
"criterions": [
{
"exact_snippets": "Need to use proton pump inhibitors",
"criterion": "proton pump inhibitors",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "H2-receptor antagonists for the dose escalation portion of the study",
"criterion": "H2-receptor antagonists",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Need to use proton pump inhibitors",
"criterion": "proton pump inhibitors",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "H2-receptor antagonists for the dose escalation portion of the study",
"criterion": "H2-receptor antagonists",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Unable to transition off strong or moderate CYP3A4 inhibitors or strong inducers",
"criterions": [
{
"exact_snippets": "Unable to transition off strong or moderate CYP3A4 inhibitors",
"criterion": "CYP3A4 inhibitors",
"requirement": {
"requirement_type": "transition ability",
"expected_value": true
}
},
{
"exact_snippets": "Unable to transition off ... strong inducers",
"criterion": "CYP3A4 inducers",
"requirement": {
"requirement_type": "transition ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Unable to transition off strong or moderate CYP3A4 inhibitors",
"criterion": "CYP3A4 inhibitors",
"requirement": {
"requirement_type": "transition ability",
"expected_value": true
}
},
{
"exact_snippets": "Unable to transition off ... strong inducers",
"criterion": "CYP3A4 inducers",
"requirement": {
"requirement_type": "transition ability",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Pregnancy or intent to breastfeed or conceive a child within the projected duration of treatment",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "intent to breastfeed",
"criterion": "intent to breastfeed",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "intent to ... conceive a child within the projected duration of treatment",
"criterion": "intent to conceive a child",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "intent to breastfeed",
"criterion": "intent to breastfeed",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "intent to ... conceive a child within the projected duration of treatment",
"criterion": "intent to conceive a child",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "Other inclusion and exclusion criteria as defined in the study protocol",
"criterions": [
{
"exact_snippets": "inclusion and exclusion criteria",
"criterion": "inclusion and exclusion criteria",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "inclusion and exclusion criteria",
"criterion": "inclusion and exclusion criteria",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
}
],
"miscellaneous_lines": [
{
"identified_line": {
"line": "Key",
"criterions": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirement": {
"requirement_type": "availability",
"expected_value": true
}
},
{
"exact_snippets": "Tissue from tumor ... > 2 cm in diameter.",
"criterion": "tumor tissue",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirement": {
"requirement_type": "availability",
"expected_value": true
}
},
{
"exact_snippets": "Tissue from tumor ... > 2 cm in diameter.",
"criterion": "tumor tissue",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
}
]
}
}
],
"failed_inclusion": [
{
"identified_line": {
"line": "* Patients with histologically confirmed solid tumors who have locally recurrent or metastatic disease, including HGSOC",
"criterions": [
{
"exact_snippets": "histologically confirmed solid tumors",
"criterion": "solid tumors",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "locally recurrent or metastatic disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"locally recurrent",
"metastatic"
]
}
},
{
"exact_snippets": "including HGSOC",
"criterion": "HGSOC",
"requirement": {
"requirement_type": "inclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed solid tumors",
"criterion": "solid tumors",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"or_criteria": [
{
"exact_snippets": "locally recurrent or metastatic disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": "locally recurrent"
}
},
{
"exact_snippets": "locally recurrent or metastatic disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": "metastatic"
}
}
]
}
]
},
{
"exact_snippets": "including HGSOC",
"criterion": "HGSOC",
"requirement": {
"requirement_type": "inclusion",
"expected_value": true
}
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Any other concurrent anti-cancer treatment, except for hormonal blockade",
"criterions": [
{
"exact_snippets": "Any other concurrent anti-cancer treatment",
"criterion": "concurrent anti-cancer treatment",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "except for hormonal blockade",
"criterion": "hormonal blockade",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"and_criteria": [
{
"exact_snippets": "Any other concurrent anti-cancer treatment",
"criterion": "concurrent anti-cancer treatment",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"not_criteria": {
"exact_snippets": "except for hormonal blockade",
"criterion": "hormonal blockade",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Clinically significant (ie, active) or uncontrolled cardiovascular disease",
"criterions": [
{
"exact_snippets": "Clinically significant (ie, active) or uncontrolled cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "status",
"expected_value": [
"clinically significant",
"active",
"uncontrolled"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "Clinically significant (ie, active) or uncontrolled cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "status",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "Clinically significant (ie, active) or uncontrolled cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "status",
"expected_value": "active"
}
},
{
"exact_snippets": "Clinically significant (ie, active) or uncontrolled cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "status",
"expected_value": "uncontrolled"
}
}
]
}
]
}
}
],
"failed_miscellaneous": []
}